For the Inventor, By the Inventor

Enter assignee name

Merckle Gmbh

USPTO Granted Patents = 26

EPO Patents = 3

Forward Citations = 240

Loading Chart...

Loading Chart...

42 inventors (with patents filed for the assignee):

Stefan Laufer (12 out of 21 patents)

Hans-Guenter Striegel (6 out of 6 patents)

Gerd Dannhardt (5 out of 13 patents)

4. Karola Tollmann (5 out of 6 patents)

5. Philipp Merckle (4 out of 4 patents)

6. Gunter Metz (4 out of 8 patents)

7. Thomas Kammermeier (3 out of 3 patents)

8. Matthias Lehr (3 out of 3 patents)

9. Kurt Rauchle (3 out of 3 patents)

10. Hans Gunther Striegel (3 out of 3 patents)

11. Wolfgang Albrecht (2 out of 42 patents)

12. Susanne Tries (2 out of 2 patents)

13. Eberhard P Hofer (2 out of 2 patents)

14. Christian Rembe (2 out of 2 patents)

15. Manfred Erdmann (1 out of 3 patents)

26 patents: Sort by Forward Citations

1. 8034837 - Polymorphic form of 6-(4-chlorophenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1h-pyrrolizin-5-ylacetic acid (2011-10-11),

2. 7608633 - [object Object] (2009-10-27),

3. 7442713 - 2-thio-substituted imidazole derivatives and their use in pharmaceutics (2008-10-28),

4. 7425573 - Use of annellated pyrrole compounds in the treatment of articular cartilage or subchondral bone degeneration (2008-09-16),

5. 7271154 - Antibiotic conjugates (2007-09-18),

6. 7253191 - 2-thio-substituted imidazole derivatives and the use thereof in the pharmaceutical industry (2007-08-07),

7. 7078535 - Method for the production of 6-(4-chlorophenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1h-pyrrolizin-5-ylacetic acid (2006-07-18),

8. 6936632 - Fused pyrrole compounds, pharmaceutical agents containing the same, and the use thereof (2005-08-30),

9. 6930094 - Tissue factor for influencing blood vessel formation (2005-08-16),

10. 6878738 - Anti-inflammatory oxo derivatives and hydroxy derivatives of pyrrolizines, and their pharmaceutical use (2005-04-12),

11. 6867211 - 4-Pyridyl-and 2,4-pyrimidinyl-substituted pyrrole derivatives and their use in pharmacy (2005-03-15),

12. 6627200 - Utilization of CD 137 in order to promote the proliferation of peripheral monocytes (2003-09-30),

13. 6544775 - Automated macromolecule synthesizing process and device (2003-04-08),

14. 6505914 - Microactuator based on diamond (2003-01-14),

15. 6432988 - 2-arylalkylthio -imidazoles, 2-arylalkenyl -thio -imidazoles and 2-arylalkinyl -thio -imidazoles as anti -inflammatory substances and substances inhibiting the release of cytokine (2002-08-13),

Merckle GmbH is a German multinational conglomerate company specializing in pharmaceuticals and chemicals. With a history dating back to 1933, the company operates in various sectors including healthcare, life sciences, and performance materials. Merckle GmbH is committed to developing innovative solutions that improve the quality of life for people worldwide.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

26 Patents

#7 in Ulm

#1,820 in Germany

#24,093 in the World

Merckle Gmbh

Forward Citations = 240

42 inventors:

Stefan Laufer (12 out of 21 patents)

Hans-Guenter Striegel (6 out of 6 patents)

Gerd Dannhardt (5 out of 13 patents)

4. Karola Tollmann (5 out of 6 patents)

5. Philipp Merckle (4 out of 4 patents)

Please report any incorrect information to support@idiyas.com

Loading…